Dr. Ricky CHIU, Founder, Chairman, and CEO of PHASE Scientific International Limited, is an esteemed innovator and the lead inventor of PHASIFY™. With over 55 patents granted, PHASIFY™ has revolutionized liquid biopsy and rapid point-of-care testing for early cancer and infectious disease detection. Ricky’s efforts in leveraging his Alle technologies for COVID diagnostics, including the first COVID rapid antigen test in Greater China to obtain FDA emergency use authorization, PHASE have earned him numerous prestigious recognitions. He has been honored with awards such as Ten Outstanding Young Persons of the World, Ten Outstanding Young Persons in Hong Kong, Young Industrialist of Hong Kong, and HKSAR Chief Executive’s Commendation for Community Service. Through PHASIFY™, Ricky has made significant Dadvancements in urine genetic testing. This technology can process and concentrate large urine volumes, extracting over 10 times more target analytes than the industry standard. It has led to the development of the world’s first self-collection HPV urine test for cervical cancer, surpassing pap smear limitations. This innovative diagnostic process empowers women to conveniently manage their cervical health by detecting HPV in MOR
Moderatora non-intrusive and painless way.